Pain Management Has Changed: Can Your Workflows Keep Up?

Pain management in ambulatory surgery centers has changed significantly over the past several years. Non-opioid alternatives are more widely available, more clinically supported, and increasingly practical from a reimbursement standpoint, driven in part by changes under the NOPAIN Act. Clinical teams have adapted quickly. Formularies have expanded. Protocols have evolved, sometimes multiple times within a single year. 

What has not always evolved at the same pace are the operational processes behind those changes. 

When a new medication is added to a pain management protocol, the clinical decision is usually straightforward. A physician recommends it, leadership approves it, and the team begins incorporating it into patient care. The harder part is ensuring the workflows surrounding that medication evolve alongside it. Tracking processes, reconciliation procedures, staff training, and documentation standards often lag behind the clinical change itself. 

That gap is easy to overlook in the moment. It becomes much harder to explain during an audit, investigation, or discrepancy review. 

Formulary Changes Add Operational Complexity

On paper, adding non-opioid medications to a formulary may seem like a simple clinical update. Operationally, it introduces new layers of complexity into an already fast-moving environment. 

Each new medication raises practical workflow questions. Where is it stored? Who has access to it? How is it documented from receipt to administration to waste? During a busy OR turnover, can staff reconcile counts quickly and confidently, or are they relying on handwritten notes and end-of-shift memory to complete documentation later? 

These are the kinds of details regulators pay attention to during DEA inspections, state board surveys, and internal compliance reviews. Controlled substances carry the same accountability requirements regardless of how frequently they are used or whether they are part of a newer non-opioid protocol. Incomplete documentation, inconsistent records, or unclear reconciliation processes still create exposure for the organization. 

The clinical decision to modernize pain management protocols is important. The operational infrastructure supporting those protocols matters just as much. 

Manual Processes Were Built for a Different Environment

Many manual controlled substance tracking processes were designed around a far simpler ASC environment - one with smaller formularies, fewer medication variations, and workflows that stayed consistent year after year. 

That's no longer the reality for many modern ASCs. 

As case complexity increases and pain management strategies diversify, documentation demands grow with them. Nurses and perioperative staff are balancing more medications across more cases while working within tight schedules and rapid room turnovers. In a manual environment, even well-run teams begin encountering friction. 

Documentation may get completed after the fact instead of in real time. Waste entries become rushed during shift changes. A discrepancy identified in the morning may not get fully investigated until the end of the day because the team is focused on keeping cases moving. 

The issue is rarely a lack of diligence. More often, the workflow itself no longer matches the pace and complexity of the clinical environment. 

And when a surveyor or investigator reviews controlled substance records, they evaluate what is documented, not what staff intended to document. Missing entries, correction marks, inconsistent timestamps, and incomplete reconciliation records create uncertainty - even when patient care itself was handled appropriately. 

Lower Opioid Volume Does Not Reduce Compliance Expectations

One common assumption is that reducing opioid use also reduces compliance exposure. In practice, that is not necessarily true. 

Lower opioid volume can actually make discrepancies more noticeable. In high-volume environments, small variances may take longer to identify. In lower-volume settings, even a single discrepancy can stand out immediately. 

At the same time, regulatory expectations have not changed. DEA accountability standards do not become less stringent because an ASC has shifted toward more non-opioid pain management strategies. Audit readiness requirements remain the same regardless of formulary mix. 

ASCs that have invested heavily in improving patient care protocols should ensure their operational controls reflect that same level of attention and consistency. 

What Strong Medication Management Looks Like in Practice

When medication management processes are functioning well, they become almost invisible during the clinical day. 

Counts reconcile quickly at case end. Waste documentation happens in the moment instead of hours later. If a discrepancy occurs, staff can trace it back to a specific case, provider, or workflow point without spending hours sorting through paper logs. 

That level of consistency does not require a complicated process. It requires one designed to support the realities of modern ASC operations. 

A few practical questions are worth asking: 

• If a DEA investigator arrived tomorrow, how quickly could your team produce complete and accurate records?  

• If a discrepancy appeared during reconciliation, how long would it take to identify the source?  

• When new medications are added to the formulary, does the tracking process adapt cleanly, or are temporary workarounds being layered onto an already manual system?  

For many ASCs, those questions reveal where operational strain is beginning to build. 

Building Infrastructure That Can Keep Pace

The organizations managing this transition most effectively are not always the largest or most heavily staffed. They are the ones investing in systems and workflows designed for how ASCs operate today.

That means reducing reliance on manual documentation where possible. It means giving clinical staff workflows that fit naturally into the pace of the surgical day instead of adding administrative burden on top of it. It means having real-time visibility into medication activity and maintaining accurate, audit-ready records long before a survey is scheduled.

Clinical teams have already shown they can adapt. The bigger question is whether the operational infrastructure supporting them is evolving at the same pace.

MedServe is built specifically for the ASC environment - helping teams simplify controlled substance tracking, reduce manual documentation burden, and maintain audit-ready records across evolving workflows.

If your processes haven't kept up with your protocols, that gap is worth a conversation.